tiprankstipranks
Trending News
More News >
DIH Holdings US, Inc Class A (DHAI)
OTHER OTC:DHAI
US Market

DIH Holdings US, Inc Class A (DHAI) AI Stock Analysis

Compare
69 Followers

Top Page

DHAI

DIH Holdings US, Inc Class A

(OTC:DHAI)

Select Model
Select Model
Select Model
Underperform 37 (OpenAI - 4o)
Rating:37Underperform
Price Target:
$0.03
▼(-6.67% Downside)
DIH Holdings US, Inc is in a precarious financial position with negative profitability, weak technical indicators, and severe corporate challenges, including Nasdaq delisting. These factors collectively contribute to a very low overall stock score, reflecting high risk and uncertainty for investors.
Positive Factors
Strategic Alliances
Strategic alliances with industry leaders can enhance product offerings and market reach, supporting long-term growth and competitive positioning.
Product Diversification
Product diversification across technology and healthcare sectors reduces dependency on a single market, providing resilience against sector-specific downturns.
Cash Flow Management
Positive free cash flow to net income ratio indicates some ability to cover losses, which is crucial for sustaining operations during financial challenges.
Negative Factors
Nasdaq Delisting
Delisting from Nasdaq impacts liquidity and investor confidence, leading to strategic uncertainty and potential operational disruptions.
Negative Profitability
Ongoing negative profitability and a weak balance sheet signal financial instability, limiting growth opportunities and strategic investments.
Revenue Decline
A decline in revenue growth rate reflects challenges in market demand or competitive pressures, potentially affecting long-term business viability.

DIH Holdings US, Inc Class A (DHAI) vs. SPDR S&P 500 ETF (SPY)

DIH Holdings US, Inc Class A Business Overview & Revenue Model

Company DescriptionDIH Holdings US, Inc Class A (DHAI) is a diversified holding company that operates primarily in the technology and healthcare sectors. The company focuses on developing and commercializing innovative solutions that enhance operational efficiencies and improve patient outcomes. Its core products include advanced healthcare technologies, software solutions for health management, and digital health platforms designed to optimize healthcare delivery and patient engagement.
How the Company Makes MoneyDIH Holdings generates revenue through multiple streams, including the sale of its proprietary healthcare technology products, subscription fees from its software services, and partnerships with healthcare providers and institutions. The company leverages strategic alliances with industry leaders to expand its market reach and enhance its product offerings. Additionally, it may also earn revenue through consulting services related to technology integration and operational optimization within healthcare settings.

DIH Holdings US, Inc Class A Financial Statement Overview

Summary
DIH Holdings US, Inc Class A faces significant financial challenges with declining revenues, negative profitability margins, and a weak balance sheet characterized by negative equity. Cash flow issues further exacerbate the situation, although there is some ability to cover net losses with free cash flow.
Income Statement
45
Neutral
The company has experienced a decline in revenue growth rate, with a negative growth of -5.89% in the latest year. Gross profit margin remains relatively stable at 51.24%, but net profit margin is negative, indicating ongoing losses. EBIT and EBITDA margins are also negative, reflecting operational challenges.
Balance Sheet
30
Negative
The balance sheet shows a negative stockholders' equity, leading to a negative debt-to-equity ratio. Return on equity is positive but reflects the negative equity base. The equity ratio is negative, indicating financial instability and potential risk.
Cash Flow
40
Negative
Cash flow analysis reveals a significant decline in free cash flow growth rate, down by -343.37%. Operating cash flow to net income ratio is negative, indicating cash flow issues. However, free cash flow to net income ratio is positive, suggesting some ability to cover net losses with free cash flow.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue62.86M62.86M64.47M55.00M49.04M47.52M
Gross Profit32.03M32.21M29.77M34.54M24.77M28.23M
EBITDA-7.11M-7.11M-6.20M652.00K-7.88M-9.63M
Net Income-8.68M-8.68M-8.44M-2.36M-12.05M-10.85M
Balance Sheet
Total Assets26.75M26.75M35.73M35.73M34.02M38.78M
Cash, Cash Equivalents and Short-Term Investments1.94M1.94M3.23M3.23M3.31M3.16M
Total Debt11.96M11.96M15.95M15.95M23.63M17.09M
Total Liabilities63.89M63.89M68.28M68.28M60.44M54.96M
Stockholders Equity-37.13M-37.13M-32.55M-32.55M-26.42M-16.18M
Cash Flow
Free Cash Flow-4.68M-4.68M4.99M6.02M-1.71M-5.74M
Operating Cash Flow-4.14M-4.14M5.19M6.18M-744.00K-4.99M
Investing Cash Flow-536.00K-536.00K-202.00K-163.00K-969.00K-1.12M
Financing Cash Flow3.39M3.39M-4.95M-3.66M2.04M2.16M

DIH Holdings US, Inc Class A Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.03
Price Trends
50DMA
3.18
Negative
100DMA
4.74
Negative
200DMA
6.01
Negative
Market Momentum
MACD
-0.98
Negative
RSI
20.90
Positive
STOCH
1.63
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DHAI, the sentiment is Negative. The current price of 0.03 is below the 20-day moving average (MA) of 1.15, below the 50-day MA of 3.18, and below the 200-day MA of 6.01, indicating a bearish trend. The MACD of -0.98 indicates Negative momentum. The RSI at 20.90 is Positive, neither overbought nor oversold. The STOCH value of 1.63 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DHAI.

DIH Holdings US, Inc Class A Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
49
Neutral
$12.22M-0.38-197.26%-2.47%91.23%
48
Neutral
$9.11M-0.5320.03%-99.28%-46.16%
44
Neutral
$7.83M-0.50-207.19%-5.19%-0.81%
40
Underperform
$6.12M-220.42%-41.03%35.71%
38
Underperform
$6.99M-1.56-69.61%-11.31%47.64%
37
Underperform
$6.07K>-0.01
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DHAI
DIH Holdings US, Inc Class A
0.03
-32.22
-99.91%
SSKN
Strata Skin Sciences
1.30
-1.75
-57.38%
BMRA
Biomerica
2.39
0.26
12.21%
PAVM
PAVmed
0.30
-0.30
-50.00%
TNON
Tenon Medical, Inc.
1.06
-0.86
-44.79%
HSCS
Heart Test Laboratories, Inc.
2.21
-1.21
-35.38%

DIH Holdings US, Inc Class A Corporate Events

Delistings and Listing ChangesBusiness Operations and Strategy
DIH Holdings Faces Nasdaq Delisting and Trading Suspension
Negative
Nov 6, 2025

On November 5, 2025, DIH Holding US, Inc. received a determination letter from Nasdaq indicating that the company’s request to continue its listing was denied, leading to the delisting of its shares and suspension of trading on November 7, 2025. The company does not intend to request a review of this decision, and as a result, its shares will be traded over-the-counter, which may adversely affect their trading price and liquidity. Additionally, the company has decided to suspend its operations due to the delisting and the inability to secure additional capital, while it evaluates strategic alternatives.

Private Placements and FinancingRegulatory Filings and Compliance
DIH Holdings US Enters $22M Stock Purchase Agreement
Neutral
Oct 21, 2025

On October 15, 2025, DIH Holdings US, Inc. entered into a purchase agreement with an investor to sell up to $22 million in Class A common stock or 10,458,031 shares, representing 19.99% of the company’s voting power. The company plans to use the proceeds for working capital and general purposes, with the agreement allowing the investor to purchase shares at a discounted price. The issuance is exempt from registration under the Securities Act, with a registration statement to be filed for resale. The agreement will terminate automatically after 36 months unless terminated earlier.

Shareholder MeetingsStock Split
DIH Holdings US Implements Reverse Stock Split
Neutral
Oct 17, 2025

On October 17, 2025, DIH Holding US, Inc. implemented a one-for-twenty-five reverse stock split of its Class A common stock, following approval from its stockholders on September 25, 2025. The reverse stock split, effective at market open on October 20, 2025, aims to consolidate shares without affecting the total authorized shares or the par value, with stockholders receiving whole shares in place of fractional ones. This move is expected to streamline the company’s stock structure while maintaining stockholder ownership percentages and voting power.

Delistings and Listing ChangesRegulatory Filings and Compliance
DIH Holdings Faces Nasdaq Delisting Threat
Negative
Oct 8, 2025

DIH Holdings US, Inc. is facing potential delisting from the Nasdaq Stock Market due to non-compliance with several listing rules. The company has failed to meet the minimum market value of publicly held shares, market value of listed securities, and bid price requirements, as well as filing deadlines for financial reports. Despite requesting a hearing and an extension to address these deficiencies, there is no assurance that the Nasdaq Hearings Panel will grant the company’s request for continued listing or that it will achieve compliance within the allowed timeframe.

Delistings and Listing ChangesRegulatory Filings and Compliance
DIH Holdings Faces Delisting Risk Amid Nasdaq Notice
Negative
Oct 2, 2025

On March 11, 2025, DIH Holding US, Inc. received a notice from Nasdaq that its Class A common stock had closed below $1.00 for 30 consecutive business days, risking delisting under Nasdaq’s Bid Price Rule. By September 12, 2025, the company had not regained compliance and faced additional delisting risks due to delays in filing required financial reports. DIH requested a hearing to present a compliance plan and sought an extension to meet Nasdaq’s listing criteria, but there is no assurance of a favorable outcome.

Private Placements and FinancingShareholder MeetingsStock Split
DIH Holdings Approves Key Proposals at Special Meeting
Positive
Sep 26, 2025

On September 25, 2025, DIH Holding US, Inc. held a Special Meeting where several proposals were presented and approved by the shareholders. These proposals included the approval of potential issuance of more than 19.99% of the company’s common stock, reduction of the base conversion price of debentures, amendment to allow additional investments at a reduced price, and a reverse stock split. The approval of these proposals is expected to impact the company’s financial structure and market positioning, potentially enhancing its capital management and shareholder value.

Delistings and Listing ChangesRegulatory Filings and Compliance
DIH Holdings Faces Nasdaq Delisting Notice in September
Negative
Sep 18, 2025

On March 11, 2025, DIH Holding US, Inc. received a notice from Nasdaq regarding non-compliance with the bid price rule, as its stock price had been below $1.00 for 30 consecutive days. The company was given until September 8, 2025, to regain compliance, but failed to do so, leading to an additional delisting notice on September 12, 2025. Additionally, DIH was not in compliance with filing requirements and the minimum market value of listed securities rule. The company has requested a hearing to present its compliance plan and seek an extension, but there is no assurance that Nasdaq will grant the request.

Shareholder MeetingsBusiness Operations and Strategy
DIH Holdings Amends By-Laws to Reduce Quorum
Neutral
Sep 12, 2025

On September 10, 2025, DIH Holding US, Inc. announced a change to its corporate governance structure by amending its By-Laws to reduce the quorum requirement from a majority to one-third of the shares outstanding. This adjustment could potentially streamline decision-making processes and impact shareholder influence in company meetings.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 09, 2025